Persistence, Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 13, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.31334?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091322

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: Researchers assessed SARS-CoV-2 spike antibody levels and their association with subsequent infection among 2,100 West Virginia nursing home residents and staff who had previously received SARS-CoV-2 vaccination.

Authors: Sally Hodder, M.D., of the West Virginia University School of Medicine in Morgantown, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.31334)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.